Encompass Health Corp — Form 10-Q
Filed August 7, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Mark J. Tarr (CEO) and Douglas E. Coltharp (CFO) certified on August 7, 2026 that the Q2 2026 Form 10-Q fairly presents financial condition and results of operations, and that disclosure controls and internal controls over financial reporting are effective. The filing includes an updated list of 169+ subsidiary guarantors of senior unsecured notes as of June 30, 2026, including rehabilitation hospital operating entities and real estate subsidiaries across multiple states. No specific financial results, changes in debt obligations, or material events are disclosed in the exhibits provided.
Why this rating
Routine periodic executive certifications and subsidiary listing. No new financial data, transactions, or material changes disclosed in exhibits.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.